Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Multiple Shape Coexistence in ^{110,112}Cd.

Garrett PE, Rodríguez TR, Varela AD, Green KL, Bangay J, Finlay A, Austin RAE, Ball GC, Bandyopadhyay DS, Bildstein V, Colosimo S, Cross DS, Demand GA, Finlay P, Garnsworthy AB, Grinyer GF, Hackman G, Jigmeddorj B, Jolie J, Kulp WD, Leach KG, Morton AC, Orce JN, Pearson CJ, Phillips AA, Radich AJ, Rand ET, Schumaker MA, Svensson CE, Sumithrarachchi C, Triambak S, Warr N, Wong J, Wood JL, Yates SW.

Phys Rev Lett. 2019 Oct 4;123(14):142502. doi: 10.1103/PhysRevLett.123.142502.

PMID:
31702191
2.

Canakinumab for Atherosclerotic Disease.

Rothman AM, Morton AC, Crossman DC; MRC-ILA Heart investigators.

N Engl J Med. 2018 Jan 11;378(2):197-8. doi: 10.1056/NEJMc1714635. No abstract available.

3.

Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction.

Thomas MR, Morton AC, Hossain R, Chen B, Luo L, Shahari NN, Hua P, Beniston RG, Judge HM, Storey RF.

Thromb Haemost. 2016 Jul 4;116(1):96-102. doi: 10.1160/TH16-02-0102. Epub 2016 Apr 21.

PMID:
27099137
4.

Charge state breeding experiences and plans at TRIUMF.

Ames F, Marchetto M, Mjøs A, Morton AC.

Rev Sci Instrum. 2016 Feb;87(2):02B501. doi: 10.1063/1.4932317.

PMID:
26932054
5.

Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation.

Thompson PL, Morton AC.

Panminerva Med. 2016 Mar;58(1):23-33. Epub 2015 Dec 11. Review.

PMID:
26658287
6.

Association of MicroRNAs and YRNAs With Platelet Function.

Kaudewitz D, Skroblin P, Bender LH, Barwari T, Willeit P, Pechlaner R, Sunderland NP, Willeit K, Morton AC, Armstrong PC, Chan MV, Lu R, Yin X, Gracio F, Dudek K, Langley SR, Zampetaki A, de Rinaldis E, Ye S, Warner TD, Saxena A, Kiechl S, Storey RF, Mayr M.

Circ Res. 2016 Feb 5;118(3):420-432. doi: 10.1161/CIRCRESAHA.114.305663. Epub 2015 Dec 8.

7.

Percutaneous brachial artery access for coronary artery procedures: Feasible and safe in the current era.

Parviz Y, Rowe R, Vijayan S, Iqbal J, Morton AC, Grech ED, Hall I, Gunn J.

Cardiovasc Revasc Med. 2015 Dec;16(8):447-9. doi: 10.1016/j.carrev.2015.08.004. Epub 2015 Aug 21.

PMID:
26365607
8.

Anti-inflammatory therapies in myocardial infarction.

Abbate A, Morton AC, Crossman DC.

Lancet. 2015 Jun 27;385(9987):2573-4. doi: 10.1016/S0140-6736(15)61153-9. No abstract available.

PMID:
26122154
9.

When is rotational angiography superior to conventional single-plane angiography for planning coronary angioplasty?

Morris PD, Taylor J, Boutong S, Brett S, Louis A, Heppenstall J, Morton AC, Gunn JP.

Catheter Cardiovasc Interv. 2016 Mar;87(4):E104-12. doi: 10.1002/ccd.26032. Epub 2015 May 27.

10.

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.

Morton AC, Rothman AM, Greenwood JP, Gunn J, Chase A, Clarke B, Hall AS, Fox K, Foley C, Banya W, Wang D, Flather MD, Crossman DC.

Eur Heart J. 2015 Feb 7;36(6):377-84. doi: 10.1093/eurheartj/ehu272. Epub 2014 Jul 30.

11.

Stability of VerifyNow P2Y12 assay results with citrate anticoagulation as compared to hirudin anticoagulation over 20-min period.

Sumaya W, Joshi RR, Judge HM, Ecob R, Morton AC, Storey RF.

Platelets. 2015;26(3):271-3. doi: 10.3109/09537104.2013.867938. Epub 2014 Jan 16. No abstract available.

PMID:
24433152
12.

Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes.

Joshi RR, Hossain R, Morton AC, Ecob R, Judge HM, Wales C, Walker JV, Karunakaran A, Storey RF.

Platelets. 2014;25(6):416-22. doi: 10.3109/09537104.2013.836175. Epub 2013 Oct 10.

PMID:
24111601
13.

Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.

Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, Morton AC, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG.

JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047. doi: 10.1016/j.jcmg.2013.01.013. Epub 2013 Jun 13.

14.

Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation.

Prentice JR, Clark MJ, Hoggard N, Morton AC, Tooth C, Paley MN, Stockley I, Hadjivassiliou M, Wilkinson JM.

PLoS One. 2013 Jun 10;8(6):e66186. doi: 10.1371/journal.pone.0066186. Print 2013.

15.

Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting.

Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J.

EuroIntervention. 2013 May 20;9(1):62-9. doi: 10.4244/EIJV9I1A10.

16.

Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.

Malkin CJ, George V, Ghobrial MS, Krishnan A, Siotia A, Raina T, Morton AC, Gunn J.

EuroIntervention. 2013 Mar;8(11):1286-95. doi: 10.4244/EIJV8I11A197.

17.

Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions: results from the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) study.

Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, Gunn JP.

JACC Cardiovasc Interv. 2013 Feb;6(2):149-57. doi: 10.1016/j.jcin.2012.08.024.

18.

The apex beat.

Morris PD, Warriner DR, Saraf K, Morton AC.

Br J Hosp Med (Lond). 2013 Feb;74(2):C23-5. No abstract available.

PMID:
23411910
19.

Hirudin anticoagulation allows more rapid determination of P2Y₁₂ inhibition by the VerifyNow P2Y12 assay.

Sumaya W, Daly RL, Mehra S, Dhutia AJ, Howgego KE, Ecob R, Judge HM, Morton AC, Storey RF.

Thromb Haemost. 2013 Mar;109(3):550-5. doi: 10.1160/TH12-10-0718. Epub 2013 Jan 10.

PMID:
23306859
20.

Simultaneous kissing drug-eluting stents to treat unprotected left main stem bifurcation disease: medium term outcome in 150 consecutive patients.

Siotia A, Morton AC, Malkin CJ, Raina T, Gunn J.

EuroIntervention. 2012 Oct;8(6):691-700. doi: 10.4244/EIJV8I6A108.

21.

Impact of incomplete revascularization in patients undergoing PCI for unprotected left main stem stenosis.

Malkin CJ, Ghobrial MS, Raina T, Siotia A, Morton AC, Gunn J.

Catheter Cardiovasc Interv. 2013 May;81(6):939-46. doi: 10.1002/ccd.24695. Epub 2013 Feb 14.

PMID:
23074075
22.

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension.

Condliffe R, Pickworth JA, Hopkinson K, Walker SJ, Hameed AG, Suntharaligam J, Soon E, Treacy C, Pepke-Zaba J, Francis SE, Crossman DC, Newman CM, Elliot CA, Morton AC, Morrell NW, Kiely DG, Lawrie A.

Pulm Circ. 2012 Jan-Mar;2(1):21-7. doi: 10.4103/2045-8932.94819.

23.

Contemporary management of ST-segment elevation myocardial infarction.

Karunakaran A, Sumaya W, Gunn JP, Morton AC, Storey RF.

Hosp Pract (1995). 2012 Feb;40(1):224-31. doi: 10.3810/hp.2012.02.963.

PMID:
22406898
24.

Novel use of a pericardium-covered stent graft to treat bulky coronary artery thrombus.

Gunn J, Siotia A, Malkin CJ, Iqbal J, Raina T, Morton AC.

Catheter Cardiovasc Interv. 2012 Jul 1;80(1):59-64. doi: 10.1002/ccd.23184. Epub 2011 Dec 8.

PMID:
22162264
25.

Beta-delayed deuteron emission from (11)Li: decay of the halo.

Raabe R, Andreyev A, Borge MJ, Buchmann L, Capel P, Fynbo HO, Huyse M, Kanungo R, Kirchner T, Mattoon C, Morton AC, Mukha I, Pearson J, Ponsaers J, Ressler JJ, Riisager K, Ruiz C, Ruprecht G, Sarazin F, Tengblad O, Van Duppen P, Walden P.

Phys Rev Lett. 2008 Nov 21;101(21):212501. Epub 2008 Nov 18.

PMID:
19113404
26.

Internal gamma decay and the superallowed branching ratio for the beta(+) emitter (38)K(m).

Leach KG, Svensson CE, Ball GC, Leslie JR, Austin RA, Bandyopadhyay D, Barton C, Bassiachvilli E, Ettenauer S, Finlay P, Garrett PE, Grinyer GF, Hackman G, Melconian D, Morton AC, Mythili S, Newman O, Pearson CJ, Pearson MR, Phillips AA, Savajols H, Schumaker MA, Wong J.

Phys Rev Lett. 2008 May 16;100(19):192504. Epub 2008 May 16.

PMID:
18518447
27.

Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study).

Crossman DC, Morton AC, Gunn JP, Greenwood JP, Hall AS, Fox KA, Lucking AJ, Flather MD, Lees B, Foley CE.

Trials. 2008 Feb 25;9:8. doi: 10.1186/1745-6215-9-8.

28.

Current challenges in coronary stenting: from bench to bedside.

Morton AC, Walker RD, Gunn J.

Biochem Soc Trans. 2007 Nov;35(Pt 5):900-4. Review.

PMID:
17956241
29.

Targeting drug-eluting stents to lesions at high risk of restenosis: a flawed approach?

Siotia AK, Morton AC, Mofidi S, Wales C, Newman C, Gunn J.

Heart. 2007 Feb;93(2):251-2. No abstract available.

30.

Simultaneous kissing stent technique to treat left main stem bifurcation disease.

Morton AC, Siotia A, Arnold ND, Korgul P, Bowles J, Heppenstall J, Gunn J.

Catheter Cardiovasc Interv. 2007 Feb 1;69(2):209-15.

PMID:
17195202
31.

A case of autotransfusion from pericardium to femoral vein.

Morton AC, Gunn J.

Heart. 2006 Dec;92(12):1727. No abstract available.

32.

Precision branching ratio measurement for the superallowed beta+ emitter 62Ga and isospin-symmetry-breaking corrections in A>or=62 nuclei.

Hyland B, Svensson CE, Ball GC, Leslie JR, Achtzehn T, Albers D, Andreoiu C, Bricault P, Churchman R, Cross D, Dombsky M, Finlay P, Garrett PE, Geppert C, Grinyer GF, Hackman G, Hanemaayer V, Lassen J, Lavoie JP, Melconian D, Morton AC, Pearson CJ, Pearson MR, Phillips AA, Schumaker MA, Smith MB, Towner IS, Valiente-Dobón JJ, Wendt K, Zganjar EF.

Phys Rev Lett. 2006 Sep 8;97(10):102501. Epub 2006 Sep 7.

PMID:
17025808
33.

Relative importance of the components of stent geometry to stretch induced in-stent neointima formation.

Dean CJ, Morton AC, Arnold ND, Hose DR, Crossman DC, Gunn J.

Heart. 2005 Dec;91(12):1603-4. No abstract available.

34.

Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model.

Morton AC, Arnold ND, Gunn J, Varcoe R, Francis SE, Dower SK, Crossman DC.

Cardiovasc Res. 2005 Dec 1;68(3):493-501. Epub 2005 Aug 15.

PMID:
16099441
35.

Half-life of the doubly magic r-process nucleus 78Ni.

Hosmer PT, Schatz H, Aprahamian A, Arndt O, Clement RR, Estrade A, Kratz KL, Liddick SN, Mantica PF, Mueller WF, Montes F, Morton AC, Ouellette M, Pellegrini E, Pfeiffer B, Reeder P, Santi P, Steiner M, Stolz A, Tomlin BE, Walters WB, Wöhr A.

Phys Rev Lett. 2005 Mar 25;94(11):112501. Epub 2005 Mar 24.

PMID:
15903849
36.

The influence of physical stent parameters upon restenosis.

Morton AC, Crossman D, Gunn J.

Pathol Biol (Paris). 2004 May;52(4):196-205. Review.

PMID:
15145132
37.

Lowest excitations in 56Ti and the predicted N=34 shell closure.

Liddick SN, Mantica PF, Janssens RV, Broda R, Brown BA, Carpenter MP, Fornal B, Honma M, Mizusaki T, Morton AC, Mueller WF, Otsuka T, Pavan J, Stolz A, Tabor SL, Tomlin BE, Wiedeking M.

Phys Rev Lett. 2004 Feb 20;92(7):072502. Epub 2004 Feb 20.

PMID:
14995845
38.
39.

Methotrexate eluting stents: to modify or cure?

Morton AC, Gunn J.

Heart. 2004 Feb;90(2):121-2. No abstract available.

40.

Drug eluting stents: maximising benefit and minimising cost.

Gunn J, Morton AC, Wales C, Newman CM, Crossman DC, Cumberland DC.

Heart. 2003 Feb;89(2):127-31.

41.

Stenting the stent.

Morton AC, Gunn J.

J Invasive Cardiol. 2002 Aug;14(8):447-51.

PMID:
12147874
42.

Epidemiology of Rhodococcus equi strains on Thoroughbred horse farms.

Morton AC, Begg AP, Anderson GA, Takai S, Lämmler C, Browning GF.

Appl Environ Microbiol. 2001 May;67(5):2167-75.

43.

Diversity of isolates of Rhodococcus equi from Australian thoroughbred horse farms.

Morton AC, Baseggio N, Peters MA, Browning GF.

Antonie Van Leeuwenhoek. 1998 Jul-Oct;74(1-3):21-5.

PMID:
10068785
44.
45.

The effects of marking and capture on recapture frequencies of butterflies.

Morton AC.

Oecologia. 1982 Apr;53(1):105-110. doi: 10.1007/BF00377143.

PMID:
28310610

Supplemental Content

Loading ...
Support Center